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Preterm prelabor rupture of membranes (PPROM) is the most frequent complication of fetal surgery. 
Strategies to seal the membrane defect created by fetoscopy aiming to reduce the occurrence of 
PPROM have been attempted with little success. The objective of this study was to evaluate the 
ex‑vivo mechanical sealing properties and toxicity of four different bioadhesives integrated in 
semi‑rigid patches for fetal membranes. We performed and ex‑vivo study using term human fetal 
membranes to compare the four integrated patches composed of silicone or silicone‑polyurethane 
combined with dopaminated‑hyaluronic acid or hydroxypropyl methylcellulose (HPMC). For 
mechanical sealing properties, membranes were mounted in a multiaxial inflation device with saline, 
perforated and sealed with the 4 combinations. We measured bursting pressure and maximum 
pressure free of leakage (n = 8). For toxicity, an organ culture of membranes sealed with the patches 
was used to measure pyknotic index (PI) and lactate dehydrogenase (LDH) concentration (n = 5). All 
bioadhesives achieved appropriate bursting pressures, but only HPMC forms achieved high maximum 
pressures free of leakage. Concerning toxicity, bioadhesives showed low PI and LDH levels, suggesting 
no cell toxicity. We conclude that a semi‑rigid patch coated with HPMC achieved ex‑vivo sealing of 
iatrogenic defects in fetal membranes with no signs of cell toxicity. These results warrant further 
research addressing long‑term adhesiveness and feasibility as a sealing system for fetoscopy.
Fetoscopic surgery is used in thousands of pregnancies worldwide yearly for a variety of fetal  indications1. 
One of the main unsolved drawbacks of fetoscopy is the damage created to fetal membranes, which is thought 
to explain that iatrogenic preterm prelabor rupture of membranes (PPROM) occurs in up to 30% of  cases1,1. 
PPROM is the main complication after fetoscopy and its occurrence substantially increases the risk of preterm 
birth and perinatal  morbidity1,1.
In most instances, PPROM occurs weeks after  fetoscopy4. Previous studies have shown that human fetal 
membranes do not heal after the creation of an iatrogenic  defect5–9. However, it has also been shown how the 
natural sliding of the amnion over the chorion might provide a natural protective mechanism against  PPROM6, 
which may explain why only a very small fraction of patients have PPROM within days of the procedure. On the 
other hand, mechanical factors such as chorioamniotic membrane separation after  fetoscopy10,10 or  septostomy12 
increase the risk of PPROM weeks later. This suggests that mechanical factors interfering with the adhesion 
between chorion and decidua may be an important trigger eventually leading to PPROM.
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Several systems have been attempted to seal fetal membranes, mainly in ex-vivo studies, so far without suc-
cess. The injection of fluid adhesives, such as mussel-glues13,13 and medical  sealants15–17 needs to overcome the 
problem of applying a fluid adhesive in the amniotic fluid wet environment. The use of collagen plugs across the 
membrane defect has shown poor results when tested in clinical  conditions18,18. We hypothesized that a semi-
rigid disc patch coated with bioadhesives could seal the amniotic defect, preventing exposure of the chorion to 
amniotic fluid and reducing the risks of chorion-decidua separation. To this end, we designed a semi-rigid patch 
made up of silicone, which can be coated with different combinations of bioadhesives.
In this study we tested the proof of concept that this integrated semi-rigid disc bioadhesive patch could 
achieve effective adhesion properties in human fetal membranes similar to well known adhesives, such as 
cyanoacrylate glue, but without their limitations to intrauterine use.
Results
Patients. Fetal membranes from a total of 27 donors were collected, 22 for mechanical tests and 5 for toxic-
ity tests. Gestational age at delivery was 39.1 weeks (range 39–39.4) and mean birth weight was 3213.6 g ± 457.9. 
Indications for cesarean section were previous C-section (59.3%), breech presentation (29.6%) and more uncom-
monly placenta previa, pelvic tumors and previous pelvic floor surgery.
Bioadhesives. Four different bioadhesive-coated patches were developed, by combining a semi-rigid patch 
and a bioadhesive component. The candidates were composed of silicone-dopaminated hyaluronic acid (S-DHA), 
silicone with polyurethane-dopaminated hyaluronic acid (SPU-DHA), silicone-hydroxypropyl methylcellulose 
(S-HPMC) or silicone with polyurethane-hydroxypropyl methylcellulose (SPU-HPMC), as indicated in Table 1 
and shown in Fig. 1.
Mechanical properties. As expected, bursting pressures after perforation and sealing were much lower 
than those observed in intact membranes (intact vs. any adhesive, p < 0.05).
Membranes sealed with either cyanoacrylate or integrated systems S-DHA, SPU-DHA, S-HPMC or SPU-
HPMC showed median values of bursting pressures in the range of 16–48 mmHg, with no significant differences 
among groups (Fig. 2).
In terms of maximum pressure free of leakage (Figs. 3, 4), S- and SPU-DHA patches presented leakage at low 
pressures (medians ranging from 1.6 to 4.8 mmHg). On the contrary, S- and SPU-HPMC candidates showed leak-
age at higher pressures [S-HPMC 44.9 mmHg (IQR 38.7–54.3) and SPU-HPMC 40.5 mmHg (IQR 30.1–59.9)], 
which were significantly higher than those observed with cyanoacrylate [21.4 mmHg (IQR 16.3–32.4)], p = 0.005 
and 0.02 respectively.
Toxicity. Pyknotic index at 48 h of culture (Fig. 5) was on average below 2% in all bioadhesives tested and 
in non-exposed membranes (p = 0.483), while in positive controls with commercial adhesive it was 31.1% (IQR 
26.0–36.5), p < 0.05 (Fig. 6).
Likewise, median LDH concentration at 48 h of culture ranged from 3 to 8 U/L and was similar to non-
exposed membranes (p = 0.154). The levels of LDH were significantly higher in the positive control 1754 U/L 
(IQR 998.5–2775.5), p < 0.01 (Fig. 7).
Discussion
In this study we tested an innovative integration of a semi-rigid biocompatible patch coated with bioadhesive. 
The results demonstrated that such system can achieve effective sealing of a defect created in human membranes 
ex vivo, with similar adhesiveness to that achieved by cyanoacrylate, but without cell toxicity. These results 
open new possibilities for the development of membrane sealing systems aiming at reducing the prevalence of 
PPROM after fetoscopy.
Our sealing system is based on the concept of sealing fetal membranes from the amniotic side. This may 
offer advantages to previously tested solutions. Collagen-based plugs have shown negative results when used 
 clinically18,18. Among other reasons, plugs can migrate, increase the size of the defect and they dissolve quickly 
in most  instances18,18. In addition, a physical plug across membranes might interfere with the natural protec-
tion against PPROM provided by the sliding of the amniotic over the chorionic membrane  layers6. Among fluid 
adhesives available for medical use, cyanoacrylate glues are extremely adhesive to tissues even in wet conditions. 
However, when applied as a glue, they show non-elastic adhesion with risk of damage due to  traction20 and its 
Table 1.  Types of sealing systems and composition. DHA, dopaminated hyaluronic acid; HPMC, 
hydroxypropyl methylcellulose; S, silicone; SPU, silicone-polyurethane.
Type of patch Abbreviation Semi-rigid patch Bioadhesive component
Silicone-DHA S-DHA Medical silicone disc (450 μm-thick and 17 mm-diameter)
DHA 70–80% of dopamination, 10 mg/mL
Silicone–polyurethane-DHA SPU-DHA Medical silicone with electrospun polyurethane disc (480 μm-thick and 17 mm-diameter)
Silicone-HPMC S-HPMC Medical silicone disc (450 μm-thick and 17 mm-diameter)
HPMC 300 μL, 10 mg/ml
Silicone–polyurethane-HPMC SPU-HPMC Medical silicone with electrospun polyurethane disc (480 μm-thick and 17 mm-diameter)
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application in intrauterine environment is complex due to its non-solid condition. Previous studies have inves-
tigated the use of mussel-like glues as an alternative to  cyanoacrylate15, since they are based on a catechol side 
chain of 3,4-dihydroxyphenylalanine (DOPA) amino acid that theoretically secures strong adhesion to almost 
any surface even  underwater15,15. Indeed, dopaminated-poly(ethylene glycol) (PEG), a mussel-like bioadhesive, 
was able to achieve leak-proof closure of 3.5-mm-trocar defects while stretched in vitro15 and has shown to 
Figure 1.  Semi-rigid patches composed of silicone only or silicone combined with electrospun polyurethane. 
(a,b) Silicone patch coated with dopaminated hyaluronic acid (DHA) in anterior and lateral views. (c–e) 
Silicone with electrospun polyurethane patch in lateral, posterior and anterior views. (f) Detail: electrospun 
polyurethane.
Figure 2.  Bursting pressure (mmHg) of fetal membranes in the study groups. Distributional plots express 
median and interquartile range, n = 8. Intact: intact membrane; Cyanoacrylate: positive control; S-DHA: silicone 
with dopaminated hyaluronic acid; SPU-DHA: silicone-polyurethane with dopaminated hyaluronic acid; 
S-HPMC: silicone with hydroxypropyl methylcellulose; SPU-HPMC: silicone-polyurethane with hydroxypropyl 
methylcellulose; ns: non-significant. Figure created using Stata 14.2.
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withstand bursting pressures around 35–40 mmHg13,13. In general, the application of glues on amniotic side of 
fetal membranes in clinical conditions is  challenging13,14,22. One study reported the development and ex vivo 
testing of an umbrella-like device supported by a purpose-designed mesh as a potential solution to apply a liquid 
mussel-glue to the amnion  defect17.
In this study we tested different adhesive polymers. To achieve a system similar to the dopamination of 
mussel-glues, we produced DHA from the polysaccharide hyaluronic acid. DHA adhered initially to membranes 
in the multiaxial device and achieved bursting pressures of 16–48 mmHg, similar to those reported using other 
bioadhesives mainly based on mussel-glue-like  systems13,15,22. However, DHA showed leakage from pressures 
as low as 1.6 mmHg. We decided to evaluate HPMC polysaccharide in the study due to its natural adhesive 
 properties23. Contrary to DHA, HPMC supported high bursting pressures preventing leakage up to 40–45 mmHg. 
Regarding the composition of the semi-rigid patch, S and SPU are largely used in medical  devices24,24. Since S 
is extremely hydrophobic and poorly adherent, polyurethane was added to tune the hydrophobicity. Moreover, 
such coating reduces the stiffness of the surface in contact with the tissue, making the materials mechanically 
friendly with the amniotic membrane. We demonstrated that both materials (S and SPU), coated with HPMC, 
Figure 3.  Maximum pressure free of leakage (mmHg) supported by fetal membranes according to treatment. 
Distributional plots express median and interquartile range, n = 8. *p < 0.05, **p < 0.01, ***p < 0.001. Intact: 
intact membrane; Cyanoacrylate: positive control; S-DHA: silicone with dopaminated hyaluronic acid; 
SPU-DHA: silicone-polyurethane with dopaminated hyaluronic acid; S-HPMC: silicone with hydroxypropyl 
methylcellulose; SPU-HPMC: silicone-polyurethane with hydroxypropyl methylcellulose; ns: non-significant. 
Figure created using Stata 14.2.
Figure 4.  Representative images of leakage, rupture and completely sealed membrane. (a) Fluorescent 
light: leakage is observed as fluorescent flow through the lesion. (b) Fluorescent light: rupture of membrane 
characterized by a sudden decrease of internal pressure associated or not with an important fluorescein flow 
through the lesion (long arrow).
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Figure 5.  Histological assessment of toxic effects on fetal membrane amniotic layer (hematoxylin eosin) 
after 48 h of culture. (a,b) Non-exposed (NE) membrane at × 400 and × 1000 magnification, respectively. (c,d) 
Membrane exposed to positive control at × 400 and × 1000 magnification, respectively. In this group, pyknotic 
nucleus is identified (arrow). *Eosinophilic material corresponding to positive control.
Figure 6.  Pyknotic index of amniotic cells nuclei (in percentage) according to bioadhesive groups at 48 h of 
culture. Distributional dotplots, n = 5. *p < 0.05 (comparison between positive control and the other groups). 
NE: non-exposed cultured membrane. Positive: positive control (component B of DrSails glue); S-DHA: silicone 
with dopaminated hyaluronic acid; SPU-DHA: silicone-polyurethane with dopaminated hyaluronic acid; 
S-HPMC: silicone with hydroxypropyl methylcellulose; SPU-HPMC: silicone-polyurethane with hydroxypropyl 
methylcellulose. Figure created using Stata 14.2
6
Vol:.(1234567890)
Scientific Reports |        (2020) 10:18608  | https://doi.org/10.1038/s41598-020-75242-y
www.nature.com/scientificreports/
had a good performance ex vivo. It is important to highlight that both S and SPU patches were produced with 
a micropatterning in order to increase the contact surface and to generate friction force. These features would 
contribute to improve attachment of the bioadhesive to a slippery surface such as the fetal membrane.
This study has clinical and research implications. Preventing iatrogenic PPROM is one of the major challenges 
in fetoscopic surgery. The system here presented has some potential advantages that would make it a suitable 
candidate for clinical testing. The use of a semi-rigid patch allows insertion through a fetoscopic trocar and 
eliminates the challenges of applying in an efficient and safe fashion a liquid glue on human  membranes17. The 
biocompatible, non-absorbable nature of the materials used allows long-term use and prevents degradation in a 
biological environment, as observed with the use of other candidate systems for membrane  sealing15,15. Research 
on the feasibility of application and efficacy of the bioadhesive patches in an experimental model of fetoscopic 
surgery is now under way.
Among the strengths of the study, we used an ex vivo model with real human membranes. The adaptation 
of a previously validated  approach1326,27 with the addition of fluorescein, allowed detection of subtle leakage 
more objectively. Contrary to previous studies in which glues were tested over chorion or  myometrium13,13,13, 
we applied the sealing system over the amnion, upside down and under a fluid environment, reproducing the 
conditions of a clinical application. Finally, we challenged substantially the system using pressures far above the 
range of 15–30 mmHg of human  pregnancy29,30. Among the limitations, these ex vivo results require further 
validation in other systems evaluating long-term adhesion and feasibility in experiments simulating real clini-
cal conditions. We used term membranes and although there are no remarkable histological differences with 
preterm  membranes31, it could be argued that adhesiveness could be lower on the latter, especially due to dif-
ferences in  stiffness32.
In conclusion, an integrated semi-rigid patch using HPMC as bioadhesive achieved levels of adhesion similar 
to a well-known adhesive as cyanoacrylate glue, but with the advantage of composing a non-toxic and ready-
to-use system. The results warrant further research to test long-term adhesiveness and feasibility as a sealing 
system for fetoscopic procedures.
Figure 7.  Concentration of lactate dehydrogenase (LDH) in U/L in supernatants according to bioadhesive 
group at 48 h of culture. Distributional dotplots, n = 5. *p < 0.01 (comparison between positive control and the 
other groups). NE: non-exposed cultured membrane. Positive: positive control (component B of DrSails glue); 
S-DHA: silicone with dopaminated hyaluronic acid; SPU-DHA: silicone-polyurethane with dopaminated 
hyaluronic acid; S-HPMC: silicone with hydroxypropyl methylcellulose; SPU-HPMC: silicone-polyurethane 
with hydroxypropyl methylcellulose; ns: non-significant. Figure created using Stata 14.2.
7
Vol.:(0123456789)
Scientific Reports |        (2020) 10:18608  | https://doi.org/10.1038/s41598-020-75242-y
www.nature.com/scientificreports/
Methods
Ethical aspects. All methods were carried out in accordance with relevant guidelines and regulations of 
the ethics committee. The experimental protocols were approved by the Ethical Committee of Hospital Clinic 
(HCB/2016/0236) and of Hospital Sant Joan de Déu (PIC-40-16). Informed consent was obtained from all 
patients, none of them under 18. Confidentiality and anonymity were ensured, and data was used only for sci-
entific purposes.
Fetal membrane collection. Fetal membranes were collected after written consent from elective cesarean 
sections of singletons at term (gestational age from 37 to 41 weeks). Exclusion criteria were: clinical chorioam-
nionitis, infections (HIV, hepatitis, syphilis), disturbances of amniotic fluid (oligo or polyhydramnios at the last 
scan), maternal conditions such as hypertension, diabetes, anemia, connective tissue disorders, under nutrition, 
use of tobacco, fetal growth anomalies, major fetal malformations or chromosomal abnormalities. Patients with 
history of contractions, preterm cervical dilatation or premature rupture of membranes were also excluded.
Production of the patches and bioadhesive systems. The semi-rigid patches were produced using 
either medical silicone (S—NuSil, NuSil Technology LLC, United States) or medical silicone combined with 
electrospun polyurethane (SPU—NuSil and Bionate Thermoplastic Polycarbonate-Urethane, DSM Biomedi-
cal Headquarters, United States). Both patches were produced in a 17-mm diameter disc shape, from 450 to 
480 µm-thick. The surface was prepared for receiving the bioadhesive component by producing a 150 µm deep 
micropatterning on it, to enhance contact surface and adhesion. All sealing systems were used up to 35 days after 
their production.
Both silicone (S) and silicone-polyurethane (SPU) disc patches were coated with bioadhesive components 
composed either by dopaminated hyaluronic acid (DHA) or hydroxypropyl methylcellulose (HPMC). DHA was 
used at 10 mg/mL and oxidized with ferric chloride, with 70–80% dopamination. HPMC was used at 10 mg/mL 
after plasma activation of S or SPU.
Membrane processing. After collection, fetal membranes were separated from the placenta. Areas with 
visible clots or decidual contamination were removed. Specimens were transported to the laboratory for further 
handling in saline solution at room temperature within 30 min. Explants were cut at 2 cm from placental edge 
to avoid heterogeneity of the  tissue33 and used within 6 h. In case the membranes were not used immediately, 
samples were kept at 4 °C until use.
A total of 27 fetal membranes were needed. For mechanical experiments, each sealing system and control 
was tested 8 times with membranes from different donors, to reduce the possible effects of membrane variability 
between donors. Each fetal membrane was used, in average, for 2–5 tests, depending on the conditions of the 
membrane. For toxicity, each experiment with sealing system and control was done 5 times with membranes 
from different donors, to reduce the possible effects of membrane variability between donors.
For mechanical properties, fetal membranes were prepared as follows. Explants were cut in 7 cm diameter 
circles with scalpel. Sand papers rings (waterproof paper, no 180, ADSEng, Germany) with 50 mm inner and 
70 mm outer diameter were glued on both sides of the membrane with superglue (Super Glue-3 Original, Loc-
tite, Barcelona, Spain). Samples were kept moist with phosphate buffered saline (PBS) during the whole process. 
Before mounting the fetal membranes over the inflation device, explants were perforated with a 10Fr-metalic 
punch (3.33 mm—Karl Storz SE and Co, Germany), from chorion to amnion (simulating clinical condition) in 
the center of the circumferential membranous explant. Perforated membranes were then sealed with the dif-
ferent sealing systems or a positive control (Cyanoacrylate). Sealing systems or positive controls were placed 
with tweezers over the amnion to cover the defect and adjusted with gentle pressure for 60 s. After 2.5 min, fetal 
membranes where then mounted over the cylinder with the amnion facing a fluorescein saline solution, as fol-
lowed explained.
For toxicity experiments, samples were handled in sterile fashion and used immediately after collection. 
Membranes were cut in 6 fragments of 2 × 2 cm and applied in contact with the different experimental groups.
Mechanical properties. A multiaxial inflation device was used to evaluate the mechanical properties of 
the sealed membranes. It consists of a custom-built device that was previously characterized by Haller et al.13,13,13 
and provided to us by the Department of Mechanical Engineering of Swiss Federal Institute of Technology 
(Zurich, Switzerland). Briefly, the device consists of an aluminum cylinder with a 50 mm-inner diameter that 
was mounted by clamping membrane samples between the cylinder and a cover ring. The cylinder was con-
nected to inlet and outlet tubes. A peristaltic pump (Reglo Digital ISM834C, four channels, max 35 ml/min per 
channel, Ismatec Laboratory Pumps, Wertheim, Germany) connected to the inlet tube was used to gradually fill 
the cylinder with fluorescein 0.1% prepared in PBS (Fluorescein oculos 10%, SERB Specialty Pharmaceuticals, 
Belgium). Fluorescein was used for detection of leakage out of the iatrogenic defect.
The cylinder was inflated by increasing the solution volume with a constant pumped rate flow of 2 ml/min. 
The difference of pressure generated was measured throughout the experiment with a hydrostatic pressure sen-
sor (digital manometer, LEX 1, − 1 to 2 bar, accuracy within 0.05%, Keller, Switzerland) positioned at the outlet 
tube and connected to a computer with a converter (K-114 A USB to RS485 Converter, Keller, Switzerland). An 
UV flashlight (UV light 400 nm 51-LED flashlight) was used to improve detection of fluorescein leakage. The 
deformation of the membrane was monitored with a video camera (CMOS Camera 1280 × 1024, Color, USB2.0, 
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Intact membranes (without perforation) and membranes sealed with an industrial cyanoacrylate glue (2-ethyl 
cyanoacrylate 75%, 1,4-dihydroxybenzene, hydroquinone, quinol—Superceys Unick, Ceys S.A., Barcelona, Spain) 
were used as controls. Cyanoacrylate glue was added manually to 17-mm diameter disc-shaped silicone patches 
a few moments before the test and therefore did not compose an integrated system.
Mounted membranes were inflated by continuously increasing the pressure in the cylinder until rupture of 
the membrane. Rupture was characterized by a sudden decrease of internal pressure being associated or not with 
an important fluorescein flow through the lesion. Bursting pressure was registered. The occurrence of leakage 
before bursting pressure was defined as detection of fluorescein flow through lesion while the pressure was still 
increasing and the membrane still inflating. Maximum pressure free of leakage was also registered.
Toxicity. The toxicity test was performed as previously  reported8. Under a laminar airflow hood, the mem-
brane explants were washed in sterile PBS (PBS pH7.4-1x—Gibco by Life Technologies, USA) at 37 °C. Areas 
with visible blood clots or decidual contaminations were removed. The explants were mounted over an acellular 
collagen support (Lyostyp—B. Braun, Germany) in 12-well plates, with the chorion facing the collagen support.
Different sealing systems and controls were placed on the amnion surface of fetal membrane fragments and 
incubated with a complete culture medium for amniocytes (Amniomax—Complete Medium—Gibco by Life 
Technologies, USA) at 37 °C and 5%  CO2 air up to 48 h. Initial experiments with cyanoacrylate showed remark-
able tissue destruction. To achieve tissue integrity allowing histological evaluation it was decided to replace 
cyanoacrylate by another commercial adhesive that also works in underwater conditions (DrSails—Sailing Tech-
nologies, S.L., Spain—component B, composed of modified polyamine). Tissue and supernatants of each group 
were harvested at 48 h. The groups studied for toxicity were: non-exposed membranes (cultured membranes 
without treatment), positive control (cultured membranes with 1 ml of component B of DrSails glue—Sailing 
Technologies, S.L., Spain) and sealing systems S-DHA, SPU-DHA, S-HPMC and SPU-HPMC (cultured mem-
branes with sealing systems).
Tissue samples were fixed in 4% formalin for 24 h and embedded in paraffin. Transversal sections were 
obtained (4 µm) and stained with hematoxylin–eosin (HE). Overall morphological condition of the mem-
branes was examined and pyknotic index, which is a characteristic feature of  apoptosis35,35, was determined in 
the amnion layer to evaluate toxicity. Pyknotic and non-pyknotic nuclei were counted under light microscopy 
at 40-power magnification level (total magnification × 400) in 5 non-overlapping fields. Pyknotic nuclei were 
identified as small-sized nuclei and with highly condensed  chromatin37. The pyknotic index was calculated by 
determining the percentage of pyknotic nuclei over the total number of amniotic nuclei.
Supernatants were stored at − 20° and used for quantitative determination of cytotoxicity based on quantifica-
tion of lactate dehydrogenase (LDH) enzyme released into culture medium (ADVIA Chemistry Systems Lactate 
Dehydrogenase L-P (LDLP) assay, Siemens Healthcare S.L.U, Spain). Absorbance was read at 340/410 nm.
Statistical analysis. Categorical variables were expressed as number of cases out of total and proportion 
(%). Normal distribution was verified using standardized normal probability plots, box plot graphs and Shapiro–
Wilk normality test. Parametric data was expressed as mean ± standard deviation and non-parametric data was 
expressed as median (interquartile range). Homogeneity of variances was verified with Levene’s test. Inferential 
analysis for numeric non-parametric variables was performed using Kruskal–Wallis test with Bonferroni error 
correction or Wilcoxon rank test (Mann–Whitney). Statistical significance was defined as p value < 0.05 for all 
analysis. Data was processed using Stata 14.2 (StataCorp. 2015. Stata Statistical Software: Release 14. College 
Station, TX: StataCorp LP).
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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